Advertisement

Topics

Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA (triamcinolone acetonide extended-release injectable suspension)

09:01 EDT 13 Jun 2018 | FinanzNachrichten

DURHAM, North Carolina, June 13, 2018 /PRNewswire/ -- Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, to...

Original Article: Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA (triamcinolone acetonide extended-release injectable suspension)

NEXT ARTICLE

More From BioPortfolio on "Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA (triamcinolone acetonide extended-release injectable suspension)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...